Lancet Commission on Hypertension group position statement on the global improvement of accuracy standards for devices that measure blood pressure

: The Lancet Commission on Hypertension identified that a key action to address the worldwide burden of high blood pressure (BP) was to improve the quality of BP measurements by using BP devices that have been validated for accuracy. Currently, there are over 3000 commercially available BP devices,...

Full description

Saved in:
Bibliographic Details
Published in:Journal of hypertension Vol. 38; no. 1; p. 21
Main Authors: Sharman, James E, O'Brien, Eoin, Alpert, Bruce, Schutte, Aletta E, Delles, Christian, Hecht Olsen, Michael, Asmar, Roland, Atkins, Neil, Barbosa, Eduardo, Calhoun, David, Campbell, Norm R C, Chalmers, John, Benjamin, Ivor, Jennings, Garry, Laurent, Stéphane, Boutouyrie, Pierre, Lopez-Jaramillo, Patricio, McManus, Richard J, Mihailidou, Anastasia S, Ordunez, Pedro, Padwal, Raj, Palatini, Paolo, Parati, Gianfranco, Poulter, Neil, Rakotz, Michael K, Rosendorff, Clive, Saladini, Francesca, Scuteri, Angelo, Sebba Barroso, Weimar, Cho, Myeong-Chan, Sung, Ki-Chul, Townsend, Raymond R, Wang, Ji-Guang, Willum Hansen, Tine, Wozniak, Gregory, Stergiou, George
Format: Journal Article
Language:English
Published: Netherlands 01.01.2020
Subjects:
Blood Pressure Determination - instrumentation
Blood Pressure Determination - standards
Humans
Hypertension - diagnosis
Practice Guidelines as Topic
Sphygmomanometers - standards
ISSN:1473-5598, 1473-5598
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:: The Lancet Commission on Hypertension identified that a key action to address the worldwide burden of high blood pressure (BP) was to improve the quality of BP measurements by using BP devices that have been validated for accuracy. Currently, there are over 3000 commercially available BP devices, but many do not have published data on accuracy testing according to established scientific standards. This problem is enabled through weak or absent regulations that allow clearance of devices for commercial use without formal validation. In addition, new BP technologies have emerged (e.g. cuffless sensors) for which there is no scientific consensus regarding BP measurement accuracy standards. Altogether, these issues contribute to the widespread availability of clinic and home BP devices with limited or uncertain accuracy, leading to inappropriate hypertension diagnosis, management and drug treatment on a global scale. The most significant problems relating to the accuracy of BP devices can be resolved by the regulatory requirement for mandatory independent validation of BP devices according to the universally-accepted International Organisation for Standardization Standard. This is a primary recommendation for which there is an urgent international need. Other key recommendations are development of validation standards specifically for new BP technologies and online lists of accurate devices that are accessible to consumers and health professionals. Recommendations are aligned with WHO policies on medical devices and universal healthcare. Adherence to recommendations would increase the global availability of accurate BP devices and result in better diagnosis and treatment of hypertension, thus decreasing the worldwide burden from high BP.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1473-5598
1473-5598
DOI:10.1097/HJH.0000000000002246